ArticlePloS one2016

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells.

Serena Vella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.